Login / Signup

Direct Observation of Methylmercury and Auranofin Binding to Selenocysteine in Thioredoxin Reductase.

Ingrid J PickeringQing ChengEmérita Mendoza RengifoSusan NehzatiNatalia V DolgovaThomas KrollDimosthenis SokarasGraham N GeorgeElias S J Arnér
Published in: Inorganic chemistry (2020)
Selenoenzymes, containing a selenocysteine (Sec) residue, fulfill important roles in biology. The mammalian thioredoxin reductase selenoenzymes are key regulators of antioxidant defense and redox signaling and are inhibited by methylmercury species and by the gold-containing drug auranofin. It has been proposed that such inhibition is mediated by metal binding to Sec in the enzyme. However, direct structural observations of these classes of inhibitors binding to selenoenzymes have been few to date. Here we therefore have used extended X-ray absorption fine structure as a direct structural probe to investigate binding to the selenium site in recombinant rat thioredoxin reductase 1 (TrxR1). The results demonstrate for the first time the direct and complete binding of the metal atom of the inhibitors to the selenium atom in TrxR1 for both methylmercury and auranofin, indicating that TrxR1 inhibition indeed can be attributed to such direct metal-selenium binding.
Keyphrases
  • oxidative stress
  • molecular dynamics
  • high resolution
  • computed tomography
  • binding protein
  • electron transfer
  • adverse drug
  • silver nanoparticles
  • electronic health record
  • innate immune